Granulocyte colony-stimulating factor enhances the in vitro cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cell lines and primary blast cells
Authors:
- Sergio RutellaSRSergio Rutella
- Giuseppina BonannoGBGiuseppina Bonanno
- Annabella ProcoliAPAnnabella Procoli
- Andrea MariottiAMAndrea Mariotti
- M. Barbara LuciaMLM. Barbara Lucia
- Anna Maria ContemiACAnna Maria Contemi
- Roberto CaudaRCRoberto Cauda
- Luana FianchiLFLuana Fianchi
- Giovanni ScambiaGSGiovanni Scambia
- Livio PaganoLivio Pagano
- Giuseppe LeoneGLGiuseppe Leone
- 1 January 2006
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 34 (1) , 54-65
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin–induced cytotoxicityBlood, 2005
- CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistanceLeukemia, 2004
- Strategies for overcoming p-glycoprotein-mediated drug resistance in acute myeloblastic leukaemiaLeukemia, 2004
- Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemiaBlood, 2004
- The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicinBlood, 2004
- Multidrug resistance protein attenuates gemtuzumab ozogamicin–induced cytotoxicity in acute myeloid leukemia cellsBlood, 2003
- Differential response of human acute myeloid leukemia cells to gemtuzumab ozogamicin in vitro: role of Chk1 and Chk2 phosphorylation and caspase 3Blood, 2003
- Role for granulocyte colony–stimulating factor in the generation of human T regulatory type 1 cellsBlood, 2002
- Expression of MDR1 by Normal Bone Marrow Cells and its Implication for Leukemic HematopoiesisLeukemia & Lymphoma, 1995
- Effect of Hemopoietic Growth Factors G-CSF and pIXY 321 on the Activity of High Dose ARA-C in Human Myeloid Leukemia CellsLeukemia & Lymphoma, 1993